COVID-19 and Corporate Finance
The Review of Corporate Finance Studies · 17.10.2022 · 11 (4) · 849-879
DOI: 10.1093/rcfs/cfac025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Review of Corporate Finance Studies, online erschienen am 13.08.2022. Verfasst von Marco Pagano und 1 weiteren Autor:innen. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
We distill evidence about the effects of COVID-19 on companies. Stock price reactions to the shock differed greatly across firms, depending on their resilience to social distancing, financial flexibility, and corporate culture. The same characteristics affected the response of firms’ sales, employment, and asset growth. Despite the shock, firms expanded their balance sheets and liquidity by raising funds from banks, bonds, and equity markets. While listed firms reduced their leverage, unlisted ones, especially small and medium enterprises, increased it. Government support programs helped firms access external funding. We conclude by identifying unexplored research issues regarding the long-run effects of COVID-19 on companies. (JEL: G11, G12, G13, G21, G24, G28, G32, G33, G35, G38, H81, H84)
Zitieren
APA
Pagano, M., & Zechner, J. (2022). COVID-19 and Corporate Finance. The Review of Corporate Finance Studies, 11(4), 849-879. https://doi.org/10.1093/rcfs/cfac025
Vancouver
Pagano M, Zechner J. COVID-19 and Corporate Finance. The Review of Corporate Finance Studies. 2022;11(4):849-879. doi:10.1093/rcfs/cfac025
BibTeX
@article{Pagano2022,
author = {Pagano, Marco and Zechner, Josef},
title = {COVID-19 and Corporate Finance},
journal = {The Review of Corporate Finance Studies},
year = {2022},
volume = {11},
number = {4},
pages = {849--879},
doi = {10.1093/rcfs/cfac025}
}
EUVIMED